I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Trédan, Olivier
466
results:
Search for persons
X
Format
Online (466)
Mediatypes
Articles (Online) (120)
Bookchapter (Online) (1)
OpenAccess-fulltext (345)
Languages
english (430)
french (11)
Sorted by: Relevance
Sorted by: Year
?
1
Added value of whole‐exome and RNA sequencing in advanced a..:
Dufresne, Armelle
;
Attignon, Valéry
;
Ferrari, Anthony
...
Cancer Medicine. 13 (2024) 7 - p. , 2024
Link:
https://doi.org/10.1002/..
?
2
Bevacizumab, olaparib, and durvalumab in patients with rela..:
Freyer, Gilles
;
Floquet, Anne
;
Tredan, Olivier
...
Nature Communications. 15 (2024) 1 - p. , 2024
Link:
https://doi.org/10.1038/..
?
3
The French multicentric molecular analysis platforms and pe..:
Verlingue, Loic
;
Desevre, Marine
;
Polito, Marie
...
Acta Oncologica. 63 (2024) - p. 411-417 , 2024
Link:
https://doi.org/10.2340/..
?
4
Author Correction: Bevacizumab, olaparib, and durvalumab in..:
Freyer, Gilles
;
Floquet, Anne
;
Tredan, Olivier
...
Nature Communications. 15 (2024) 1 - p. , 2024
Link:
https://doi.org/10.1038/..
?
5
Do surgeons overestimate diaphragmatic peritoneal disease i..:
Turrel, Estelle
;
Chopin, Nicolas
;
Meeus, Pierre
...
European Journal of Surgical Oncology. 49 (2023) 9 - p. 106963 , 2023
Link:
https://doi.org/10.1016/..
?
6
La presse locale sous l'influence des plateformes numérique..:
Trédan, Olivier
;
Gestin, Philippe
Études de communication. , 2023
Link:
https://doi.org/10.4000/..
?
7
Adjuvant endocrine therapy uptake, toxicity, quality of lif..:
Balazard, Félix
;
Bertaut, Aurélie
;
Bordet, Élise
...
JNCI: Journal of the National Cancer Institute. 115 (2023) 9 - p. 1099-1108 , 2023
Link:
https://doi.org/10.1093/..
?
8
Baseline quality of life and chemotherapy toxicities in pat..:
Licaj, Idlir
;
Coquan, Elodie
;
Dabakuyo‐Yonli, Tienhan Sandrine
...
Cancer. 129 (2023) 7 - p. 1085-1095 , 2023
Link:
https://doi.org/10.1002/..
?
9
Sustainable return to work among breast cancer survivors:
Ruiz de Azua, Garazi
;
Kousignian, Isabelle
;
Vaz‐Luis, Ines
...
Cancer Medicine. 12 (2023) 18 - p. 19091-19101 , 2023
Link:
https://doi.org/10.1002/..
?
10
PRMT5 triggers glucocorticoid-induced cell migration in tri..:
Noureddine, Lara Malik
;
Ablain, Julien
;
Surmieliova-Garnès, Ausra
...
Life Science Alliance. 6 (2023) 10 - p. e202302009 , 2023
Link:
https://doi.org/10.26508..
?
11
Association of chemotherapy and comorbidities with overall ..:
Corbaux, Pauline
;
Terret, Catherine
;
Cropet, Claire
...
International Journal of Clinical Oncology. 28 (2023) 3 - p. 371-381 , 2023
Link:
https://doi.org/10.1007/..
?
12
Overall survival with sacituzumab govitecan in hormone rece..:
Rugo, Hope S
;
Bardia, Aditya
;
Marmé, Frederik
...
The Lancet. 402 (2023) 10411 - p. 1423-1433 , 2023
Link:
https://doi.org/10.1016/..
?
13
Real-world clinical and survival outcomes of patients with ..:
Grinda, Thomas
;
Antoine, Alison
;
Jacot, William
...
European Journal of Cancer. 189 (2023) - p. 112935 , 2023
Link:
https://doi.org/10.1016/..
?
14
Sorafenib in Molecularly Selected Cancer Patients: Final An..:
Trédan, Olivier
;
Toulmonde, Maud
;
Le Tourneau, Christophe
...
Cancers. 15 (2023) 13 - p. 3441 , 2023
Link:
https://doi.org/10.3390/..
?
15
MDR1-expressing CD4+T cells with Th1.17 features resist to ..:
Di Roio, Anthony
;
Hubert, Margaux
;
Besson, Laurie
...
Journal for ImmunoTherapy of Cancer. 11 (2023) 11 - p. e007733 , 2023
Link:
https://doi.org/10.1136/..
1-15